Search research articles
Contact Us
Filters
Showing results (91-100 of 126) with videos related to
Page
of 13
Sort By:
Lancet (London, England)
|
May 24, 2015
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
Sean Kehoe, Jane Hook, Matthew Nankivell, et al.
Magnetic Resonance in Medicine
|
September 1, 2007
Organ-specific effects of oxygen and carbogen gas inhalation on tissue longitudinal relaxation times
James P B O'Connor, Alan Jackson, Giovanni A Buonaccorsi, et al.
Magnetic Resonance in Medicine
|
December 20, 2008
Comparison of normal tissue R1 and R*2 modulation by oxygen and carbogen
James P B O'Connor, Josephine H Naish, Alan Jackson, et al.
Clinical Colorectal Cancer
|
December 13, 2025
Overall Survival for Bevacizumab Therapy in Metastatic Colorectal Cancer: An Updated Analysis of the TRAVASTIN Study
Rosie Maye Solomon, Robert D Morgan, Laura Horsley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2014
Biomarkers and response to bevacizumab--response
Fiona Collinson, Michelle Hutchinson, Rachel A Craven, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2013
Predicting response to bevacizumab in ovarian cancer: a panel of potential biomarkers informing treatment selection
Fiona Collinson, Michelle Hutchinson, Rachel A Craven, et al.
Cancer
|
June 3, 2019
High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum
Robert L Hollis, Michael Churchman, Caroline O Michie, et al.
Journal of Medical Genetics
|
January 27, 2019
Prevalence of germline pathogenic <i>BRCA1/2</i> variants in sequential epithelial ovarian cancer cases
Robert D Morgan, George J Burghel, Nicola Flaum, et al.
Cancers
|
February 11, 2023
Is Reflex Germline <i>BRCA1/2</i> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?
Robert D Morgan, George J Burghel, Nicola Flaum, et al.
British Journal of Cancer
|
March 9, 2022
BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing?
Robert D Morgan, George J Burghel, Nicola Flaum, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 126) with videos related to
Sort By:
Page
of 13
Lancet (London, England)
|
May 24, 2015
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
Sean Kehoe, Jane Hook, Matthew Nankivell, et al.
Magnetic Resonance in Medicine
|
September 1, 2007
Organ-specific effects of oxygen and carbogen gas inhalation on tissue longitudinal relaxation times
James P B O'Connor, Alan Jackson, Giovanni A Buonaccorsi, et al.
Magnetic Resonance in Medicine
|
December 20, 2008
Comparison of normal tissue R1 and R*2 modulation by oxygen and carbogen
James P B O'Connor, Josephine H Naish, Alan Jackson, et al.
Clinical Colorectal Cancer
|
December 13, 2025
Overall Survival for Bevacizumab Therapy in Metastatic Colorectal Cancer: An Updated Analysis of the TRAVASTIN Study
Rosie Maye Solomon, Robert D Morgan, Laura Horsley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2014
Biomarkers and response to bevacizumab--response
Fiona Collinson, Michelle Hutchinson, Rachel A Craven, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2013
Predicting response to bevacizumab in ovarian cancer: a panel of potential biomarkers informing treatment selection
Fiona Collinson, Michelle Hutchinson, Rachel A Craven, et al.
Cancer
|
June 3, 2019
High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum
Robert L Hollis, Michael Churchman, Caroline O Michie, et al.
Journal of Medical Genetics
|
January 27, 2019
Prevalence of germline pathogenic <i>BRCA1/2</i> variants in sequential epithelial ovarian cancer cases
Robert D Morgan, George J Burghel, Nicola Flaum, et al.
Cancers
|
February 11, 2023
Is Reflex Germline <i>BRCA1/2</i> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?
Robert D Morgan, George J Burghel, Nicola Flaum, et al.
British Journal of Cancer
|
March 9, 2022
BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing?
Robert D Morgan, George J Burghel, Nicola Flaum, et al.
Page
of 13